Deinove SA announced the appointment of Emmanuel Petiot, formerly Director of Sales of NOVOZYMES North America Inc. as CEO of DEINOVE. Jacques Biton, CEO since 2007, is appointed Chairman of the Scientific Advisory Board of the company. Emmanuel Petiot was previously Director of Sales of Novozymes North America Inc. For 9 years, he had a brilliant career in this Danish industrial biotechnology company, holding executive positions in marketing, sales and business development, both in Europe and the United States.

He was also General Manager of the French subsidiary of Novozymes. CEO since 2007, Jacques Biton has been the architect of the technological development of the company, making Deinococcus bacteria a unique technology platform that has already demonstrated its great potential for biomass degradation and bioethanol production. Jacques Biton is now the Chairman of the International Scientific Advisory Board of DEINOVE.